Form 8-K - Current report:
SEC Accession No. 0001193125-26-336508
Filing Date
2026-08-06
Accepted
2026-08-06 06:05:17
Documents
13
Period of Report
2026-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d158179d8k.htm   iXBRL 8-K 24848
2 EX-99.1 d158179dex991.htm EX-99.1 64760
6 GRAPHIC g158179g0806054038356.jpg GRAPHIC 4392
  Complete submission text file 0001193125-26-336508.txt   222632

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gern-20260805.xsd EX-101.SCH 3171
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20260805_lab.xml EX-101.LAB 17992
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20260805_pre.xml EX-101.PRE 11255
17 EXTRACTED XBRL INSTANCE DOCUMENT d158179d8k_htm.xml XML 3657
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 261245685
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)